VCYT - צמיחת הכנסות שנתית ב-12 החודשים האחרונים Veracyte, Inc.

סמל מסחרי של Veracyte, Inc. (VCYT)

Veracyte, Inc. (VCYT) is implementing AI and machine learning for the ultra-early detection of oncological diseases. Financial stability is based on the expansion of genetic tests and their insurance coverage. The year-over-year product sales dynamics for the TTM on the GURU.Markets chart show that the current level is 17.20. Such innovations eliminate unnecessary biopsies, which stimulates the growth of government contracts and strengthens the company's market position.

צמיחת הכנסות משנה לשנה ב-12 החודשים האחרונים: Veracyte Inc (VCYT) עבור 11.02.2024 - 16.11.2026

פילוחי נתונים אנליטיים מרוכזים עבור Veracyte (VCYT)

- שווי מניות ותחזית קונצנזוס למחירים:
אנליטיקה מסכמת של החברה:VCYT (Veracyte Corp)
מוצר המיוצר על ידי veracyte.com

The scaling dynamics of Veracyte, Inc. (VCYT) are assessed through revenue growth rates on a rolling year basis. This indicator compares current aggregate revenue with the same period last year, neutralizing quarterly volatility. By analyzing this TTM annual sales growth chart, an investor can determine the efficiency of biosample express logistics. Stable growth confirms the reliability of supply chains and the resilience of the company's market positions.